Mr. Speaker, the Standing Committee on Health studied the issue of the toxic drug crisis, and several witnesses told us that there needs to be better control of precursors, the substances used in the manufacture of drugs such as fentanyl.
I would like to know what my colleague thinks about part 2 of the bill, which gives the Minister of Health additional powers with respect to precursors.